- Home
- JILL vs OABI Comparison
JILL vs OABI Comparison
Compare JILL & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JILL
- OABI
- Stock Information
- Founded
- JILL 1959
- OABI 2012
- Country
- JILL United States
- OABI United States
- Employees
- JILL N/A
- OABI N/A
- Industry
- JILL Clothing/Shoe/Accessory Stores
- OABI Biotechnology: Pharmaceutical Preparations
- Sector
- JILL Consumer Discretionary
- OABI Health Care
- Exchange
- JILL Nasdaq
- OABI Nasdaq
- Market Cap
- JILL 375.1M
- OABI 429.6M
- IPO Year
- JILL 2017
- OABI N/A
- Fundamental
- Price
- JILL $27.27
- OABI $3.21
- Analyst Decision
- JILL Strong Buy
- OABI Strong Buy
- Analyst Count
- JILL 6
- OABI 4
- Target Price
- JILL $38.17
- OABI $9.00
- AVG Volume (30 Days)
- JILL 102.9K
- OABI 483.2K
- Earning Date
- JILL 12-11-2024
- OABI 11-12-2024
- Dividend Yield
- JILL 0.77%
- OABI N/A
- EPS Growth
- JILL 24.73
- OABI N/A
- EPS
- JILL 2.82
- OABI N/A
- Revenue
- JILL $614,918,000.00
- OABI $20,409,000.00
- Revenue This Year
- JILL $2.96
- OABI N/A
- Revenue Next Year
- JILL $3.01
- OABI $78.61
- P/E Ratio
- JILL $9.69
- OABI N/A
- Revenue Growth
- JILL 1.57
- OABI N/A
- 52 Week Low
- JILL $23.06
- OABI $3.16
- 52 Week High
- JILL $40.61
- OABI $6.55
- Technical
- Relative Strength Index (RSI)
- JILL 52.25
- OABI 31.99
- Support Level
- JILL $25.39
- OABI $3.16
- Resistance Level
- JILL $27.57
- OABI $3.37
- Average True Range (ATR)
- JILL 1.09
- OABI 0.14
- MACD
- JILL -0.05
- OABI -0.03
- Stochastic Oscillator
- JILL 60.94
- OABI 7.55
About JILL J. Jill Inc.
J.Jill Inc is a national lifestyle brand that provides apparel, footwear, and accessories. The company's products are marketed under the J.Jill brand name and sold through two channels: its e-commerce platform and catalog (Direct) and its retail stores (Retail). Revenue is derived from the sale of apparel and accessory merchandise through the company's Retail and Direct channels, which include website and catalog phone orders. Revenue also includes shipping and handling fees collected from customers.
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. The company focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.